Immuno-oncologic care during COVID-19: Challenges and opportunities for improving clinical care and investigation.
J Cancer Biol
; 2(3): 75-82, 2021.
Article
en En
| MEDLINE
| ID: mdl-35224563
ABSTRACT
Cancer care has been greatly impacted during the COVID-19 pandemic. The number of cases and deaths caused by the COVID-19 pandemic continues to escalate throughout the United States and the world. Worldwide, over 150 million people have been diagnosed with the coronavirus and more than 3 million have died. Now that we have gained additional experience with COVID-19, we are starting to learn its full impact on oncology care and its effects on the practice of medicine and clinical research.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
J Cancer Biol
Año:
2021
Tipo del documento:
Article